CDKN2A/p14ARF Recombinant Antibody, Unconjugated, Rabbit

Artikelnummer: BSS-BSM-60307R
Artikelname: CDKN2A/p14ARF Recombinant Antibody, Unconjugated, Rabbit
Artikelnummer: BSS-BSM-60307R
Hersteller Artikelnummer: bsm-60307R
Alternativnummer: BSS-BSM-60307R-100
Hersteller: Bioss
Wirt: Rabbit
Kategorie: Antikörper
Applikation: IF, WB
Spezies Reaktivität: Human
Konjugation: Unconjugated
Alternative Synonym: cyclin-dependent kinase inhibitor 2A, CDK4I, p16-INK4, p16-INK4a, cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2A, isoform 1, Cyclin dependent kinase inhibitor 2A (p16, inhibits CDK4), cell cycle inhibitor, cyclin-dependent kinase inhibitor 2a p16Ink4a, cell cycle regulator, cyclin-dependent kinase inhibitor 2a p19Arf, cyclin-dependent kinase inhibitor 2A, isoform 2, Cdkn2a, Arf, INK4A, MTS1, p16, p16Cdkn2a, p19ARF, CD2A2_HUMAN.
This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene, this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. [provided by RefSeq, Sep 2012].
Klonalität: Recombinant
Konzentration: Lot Dependent
NCBI: 1029
UniProt: Q8N726
Puffer: 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Quelle: KLH conjugated synthetic peptide derived from human P14ARF
Reinheit: Purified by Protein A.
Target-Kategorie: CDKN2A/p14ARF
Antibody Type: Primary Antibody
Application Verdünnung: WB(WB(1:500-2000)), IF(ICC)(IF(ICC)(1:100-500))